One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Paul Klee’s progressive dyspnea: A series of historical and clinical vignettes, part V
Richard M Silver
doi : 10.1177/23971983231213140
Volume 9 Issue 1, February 2024
Alveolar epithelial-to-mesenchymal transition in scleroderma interstitial lung disease: Technical challenges, available evidence and therapeutic perspectives
Enrico De Lorenzis1,2 , Christopher William Wasson1 and Francesco Del Galdo
Outcomes in systemic sclerosis patients hospitalized with COVID-19: Insight from the National Inpatient Sample
Huzaifa Ahmad Cheema1 , Anum Akhlaq2 , Biah Mustafa1 , Abia Shahid1 , Muhammad Ayyan1 and Ehizogie Edigin
Approval status of essential therapeutic drugs for systemic sclerosis versus that of drugs for rheumatoid arthritis
Ki Won Moon1* , Soo-Hee Hwang2* , Jieun Yun3 and Eun Bong Lee
Exploratory clinical subgroup clustering in systemic sclerosis: Results from the Indian Progressive Systemic Sclerosis Registry
Shery Susan Philip1 , Ramya Janardana1 , Padmanabha Shenoy2 , Chengappa Kavadichanda3 , Devender Bairwa3 , Geetabali Sircar4 , Parasar Ghosh4 , Anupam Wakhlu5 , Sumithra Selvam6 , Dinesh Khanna7 , and Vineeta Shobha1 ; for Indian Progressive Systemic Sclerosis Registry (IPSSR)
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING� (Systemic Sclerosis Progression InvestiGation) Registry
Valeria Riccieri1* , Greta Pellegrino1,2* , Edoardo Cipolletta3 , Dilia Giuggioli 4 , Gianluigi Bajocchi5 , Silvia Bellando-Randone6 , Lorenzo Dagna7 ,
Use of exercise tests in screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review
Sarah Madigan1,2 , Susanna Proudman1,3 , David Schembri2 , Huw Davies2,4 and Robert Adams
Are there more acute cardiac hospitalizations in winter in patients with systemic sclerosis? An analysis from the National Inpatient Sample
Yiming Luo1 , Laura Ross2,3 , Jiayi Zheng4 and Elana J Bernstein
Deficiency and altered phenotype of mucosal-associated invariant T cells in systemic sclerosis
Manon Lesturgie-Talarek1 , Virginie Gonzalez1 , Lucie Beaudoin1 , Camelia Frantz1 , Noémie Sénot1 , Zouriatou Gouda1 , Camille Rousseau1 , Jérôme Avouac2 , Agnès Lehuen1 and Yannick Allanore
Intensive receptor blockade and plasma exchange to treat refractory scleroderma renal crisis in patients with agonistic autoantibodies targeting the angiotensin II type 1 and endothelin-1 type A receptors
Bj?rn Hegner1,2 , Julia Callaghan3 , Ralf Schindler1,4 , Harald Heidecke5 , Gabriela Riemekasten6 , Aurélie Philippe1,7* and Rusan Catar
Recurrent episodes of Takotsubo cardiomyopathy in systemic sclerosis
Yumiko L Vreeburg1 , Daniel S Knight2 , John G Coghlan2 , Voon H Ong1,3 and Christopher P Denton
Myositis mimics in scleroderma: A case series of neuromuscular diseases that can co-exist in scleroderma
Emma Joyce1 , Fredrick M Wigley2 , Laura K Hummers2 and Julie J Paik
